Women of reproductive age are at particular risk
the selection should be driven by the target outcome
Fatigue, Dizziness, Gallbladder, or Pancreatic Concerns A minority of patients report feeling tired or lightheaded, particularly if their calorie intake has dropped significantly
The recently announced Medicare GLP-1 Bridge builds on these efforts to expand access and will provide eligible Medicare beneficiaries living with obesity access to Wegovy (semaglutide) injection and tablets for a $50 monthly copay, beginning July 1, 2026
Rybelsus is licensed for type 2 diabetes, not weight loss, and comes in doses of 1.5mg, 4mg, and 9mg
Mikuriya TH